{"id":129877,"date":"2021-11-02T13:22:58","date_gmt":"2021-11-02T20:22:58","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/11\/delta-sub-variant-expected-to-be-dominant-in-uk"},"modified":"2021-11-02T13:22:58","modified_gmt":"2021-11-02T20:22:58","slug":"delta-sub-variant-expected-to-be-dominant-in-uk","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/11\/delta-sub-variant-expected-to-be-dominant-in-uk","title":{"rendered":"Delta sub-variant expected to be dominant in UK"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/delta-sub-variant-expected-to-be-dominant-in-uk.jpg\"><\/a><\/p>\n<p>Displacing Delta. Expect this to dominate globally in the coming year, if truly 10% more transmissible.<\/p>\n<hr>\n<p>An offshoot of the <a href=\"https:\/\/www.independent.co.uk\/topic\/delta\">Delta<\/a><a href=\"https:\/\/www.independent.co.uk\/topic\/coronavirus\"> coronavirus<\/a> variant which is slowly spreading throughout the <a href=\"https:\/\/www.independent.co.uk\/topic\/uk\">UK<\/a> is expected to be dominant within a matter of months, experts believe.<\/p>\n<p>Known as AY.4.2, the sub-variant is thought to be at least 10 cent more transmissible than its predecessor, with analysis underway to determine what accounts for its increased infectiousness.<\/p>\n<p>The UK Health Security Agency (UKHSA) has said that early tests do not suggest that AY.4.2, which has been labelled a \u2018Variant Under Investigation\u2019, has acquired the ability to evade immunity generated by infection or injection.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Displacing Delta. Expect this to dominate globally in the coming year, if truly 10% more transmissible. An offshoot of the Delta coronavirus variant which is slowly spreading throughout the UK is expected to be dominant within a matter of months, experts believe. Known as AY.4.2, the sub-variant is thought to be at least 10 cent [\u2026]<\/p>\n","protected":false},"author":614,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495,1492],"tags":[],"class_list":["post-129877","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health","category-security"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/129877","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/614"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=129877"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/129877\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=129877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=129877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=129877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}